Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Novel small molecule inhibitors of nicotinamide N-methyltransferase (NNMT)
(Hims & Hers, NYSE: HIMS), the leading health and wellness platform, today shared more data on the challenges Americans are facing when trying to access branded GLP-1 medication and introduced a GLP-1 Supply Tracker, where individuals can be a part of advocating for better access to the medications they need
The most stable and commonly used form of B12 Supports cellular metabolism and energy production No fillers, preservatives, or artificial additives B12 therapy benefits a wide range of individuals experiencing fatigue, low energy, or specific health conditions Experience the transformative effects of B12 therapy on your energy, mood, and overall well-being Feel energized within minutes of treatment
According to the 2025 KFF Employer Health Benefits survey, about 1 in 5 (19%) of large firms offering health benefits say they cover costly GLP-1 drugs such as Wegovy for weight loss in 2025
To know about the assumptions considered for the study, download the pdf brochure Market Size Estimation The total size of the injectable drug delivery market was determined after data triangulation from three approaches, as mentioned below
US$ 24.82
US$ 22.15
US$ 24.33
US$ 26.01
US$ 20.55
US$ 22.19
US$ 27.53
